Abstract
Deficiency of intracellular magnesium (icMg) may coexist with normal serum Mg levels. Little is known about clinical and pharmacological factors affecting icMg in normomagnesemic patients with diabetes mellitus (DM). Moreover, no information exists regarding the icMg state in diabetic patients after acute illness and before hospital discharge. We have evaluated the effect of antihyperglycemic medications and other relevant clinical variables on icMg in 119 such patients. Total icMg was measured in peripheral blood mononuclear cells. Twenty healthy volunteers served as controls. IcMg content (µg/mg cell protein) was lower in DM compared to controls (1.74 ± 0.44 vs 2.4 ± 0.39, p < 0.001). It was also significantly lower in patients treated with insulin (1.57 ± 0.31 vs 1.8 ± 0.46, p = 0.01), while metformin treatment was associated with higher icMg (1.86 ± 0.49 vs 1.63 ± 0.35, p = 0.003). After adjustment for age, gender, and concomitant use of other hypoglycemic drugs, only treatment with metformin was independently associated with increased icMg (p = 0.03). No statistically significant association or correlation was found between icMg content and age, causes of hospitalization, comorbid conditions, treatment with other drugs, concentrations of HbA1c, serum glucose, Mg, or creatinine. In conclusion, icMg is depleted in normomagnesemic DM patients. Insulin treatment is associated with worsening of icMg status, while metformin treatment may confer protective effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Garland HO (1992) New experimental data on the relationship between diabetes mellitus and magnesium. Magnes Res 5:193–202
Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM (1993) Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:767–770
Tosiello L (1996) Hypomagnesemia and diabetes mellitus: a review of clinical implications. Arch Intern Med 156:1143–1148
de Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V (1998) The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21:682–686
Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A (2000) Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 294:1–26
Paolisso G, Barbagallo M (1997) Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 10:346–355
Barbagallo M, Dominguez LJ (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 458:40–47
Alzaid AA, Dinneen SF, Moyer TP, Rizza RA (1995) Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 80:1376–1381
Ryzen E, Elkayam U, Rude RK (1986) Low blood mononuclear cell magnesium in intensive cardiac care unit patients. Am Heart J 111:475–480
Reinhart RA, Marx JJ Jr, Haas RG, Desbiens NA (1987) Intracellular magnesium of mononuclear cells from venous blood of clinically healthy subjects. Clin Chim Acta 167:187–195
Reinhart RA (1988) Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 148:2415–2420
Douban S, Brodsky MA, Whang DD, Whang R (1996) Significance of magnesium in congestive heart failure. Am Heart J 132:664–671
Weissgarten J, Berman S, Bilchinsky R, Modai D, Averbukh Z (2001) Total cell-associated Zn++ and Cu++ and proliferative responsiveness of peripheral blood mononuclear cells from patients on chronic hemodialysis. Metabolism 50:270–276
Alon I, Berman S, Shteinshnaider M, Efrati S, Gorelik O, Almoznino-Sarafian D, Weissgarten J, Cohen N (2006) Total cellular calcium and magnesium content of cultured human peripheral blood mononuclear cells following exposure to antidiabetic drugs. Acta Diabetol 43:46–51
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Dixon WJ (ed) (1993) BMDP statistical software. University of California Press, Los Angeles, California
Sjogren A, Floren CH, Nilsson A (1988) Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 224:461–466
Delva P, Degan M, Pastori C, Faccini G, Lechi A (2002) Glucose-induced alterations of intracellular ionized magnesium in human lymphocytes. Life Sci 71:2119–2135
Sjogren A, Floren CH, Nilsson A (1986) Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 35:459–463
Ewis SA, Abdel-Rahman MS (1995) Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats. J Appl Toxicol 15:387–390
Ewis SA, Abdel-Rahman MS (1997) Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats. J Appl Toxicol 17:409–413
Matthaei S, Greten H (1991) Evidence that metformin ameliorates cellular insulin-resistance by potentiating insulin-induced translocation of glucose transporters to the plasma membrane. Diabetes Metab 17:150–158
Sjogren A, Floren CH, Nilsson A (1985) Measurements of magnesium in mononuclear cells. Sci Total Environ 42:77–82
Elin RJ (1988) Status of the determination of magnesium in mononuclear blood cells in humans. Magnesium 7:300–305
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gorelik, O., Efrati, S., Berman, S. et al. Effect of Various Clinical Variables on Total Intracellular Magnesium in Hospitalized Normomagnesemic Diabetic Patients before Discharge. Biol Trace Elem Res 120, 102–109 (2007). https://doi.org/10.1007/s12011-007-8024-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-007-8024-4